publication venue for
- Incorporating human exposure information in a weight of evidence approach to inform design of repeated dose animal studies.. -. 2021
- Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.. -. 2021
- Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE.. 71:68-77. 2014